You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 21, June 2, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (68)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •HIV/AIDS
 •Sexually Transmitted Diseases
 •World Health
 •Women's Health
 •Women's Health, Other
 •Randomized Controlled Trial
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Monthly Antibiotic Chemoprophylaxis and Incidence of Sexually Transmitted Infections and HIV-1 Infection in Kenyan Sex Workers

A Randomized Controlled Trial

Rupert Kaul, MD, PhD; Joshua Kimani, MD, MPH; Nico J. Nagelkerke, PhD; Karoline Fonck, MD, MPH; Elizabeth N. Ngugi, PhD; Florence Keli, MD; Kelly S. MacDonald, MD; Ian W. Maclean, PhD; Job J. Bwayo, MD, PhD; Marleen Temmerman, MD, PhD; Allan R. Ronald, MD; Stephen Moses, MD, MPH; for the Kibera HIV Study Group

JAMA. 2004;291:2555-2562.

Context  Sexually transmitted infections (STIs) are common in female sex workers (FSWs) and may enhance susceptibility to infection with human immunodeficiency virus type 1 (HIV-1).

Objective  To examine regular antibiotic prophylaxis in FSWs as a strategy for reducing the incidence of bacterial STIs and HIV-1.

Design, Setting, and Participants  Randomized, double-blind, placebo-controlled trial conducted between 1998-2002 among FSWs in an urban slum area of Nairobi, Kenya. Of 890 FSWs screened, 466 who were seronegative for HIV-1 infection were enrolled and randomly assigned to receive azithromycin (n = 230) or placebo (n = 236). Groups were well matched at baseline for sexual risk taking and STI rates.

Intervention  Monthly oral administration of 1 g of azithromycin or identical placebo, as directly observed therapy. All participants were provided with free condoms, risk-reduction counseling, and STI case management.

Main Outcome Measures  The primary study end point was incidence of HIV-1 infection. Secondary end points were the incidence of STIs due to Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Treponema pallidum, and Haemophilus ducreyi, as well as bacterial vaginosis. Analysis of herpes simplex virus type 2 (HSV-2) infection was performed post hoc.

Results  Seventy-three percent of participants (n = 341) were followed up for 2 or more years or until they reached an administrative trial end point. Incidence of HIV-1 did not differ between treatment and placebo groups (4% [19 cases per 473 person-years of follow-up] vs 3.2% [16 cases per 495 person-years of follow-up] rate ratio [RR], 1.2; 95% CI, 0.6-2.5). Incident HIV-1 infection was associated with preceding infection with N gonorrhoeae (rate ratio [RR], 4.9; 95% CI, 1.7-14.3) or C trachomatis (RR, 3.0; 95% CI, 1.1-8.9). There was a reduced incidence in the treatment group of infection with N gonorrhoeae (RR, 0.46; 95% CI, 0.31-0.68), C trachomatis (RR, 0.38; 95% CI, 0.26-0.57), and T vaginalis (RR, 0.56; 95% CI, 0.40-0.78). The seroprevalence of HSV-2 infection at enrollment was 72.7%, and HSV-2 infection at baseline was independently associated with HIV-1 acquisition (RR, 6.3; 95% CI, 1.5-27.1).

Conclusions  Despite an association between bacterial STIs and acquisition of HIV-1 infection, the addition of monthly azithromycin prophylaxis to established HIV-1 risk reduction strategies substantially reduced the incidence of STIs but did not reduce the incidence of HIV-1. Prevalent HSV-2 infection may have been an important cofactor in acquisition of HIV-1.


Author Affiliations: Departments of Medical Microbiology (Drs Kaul, Kimani, Fonck, Keli, and Bwayo) and Community Health (Dr Ngugi), University of Nairobi, Nairobi, Kenya; Department of Medicine, University of Toronto, Toronto, Ontario (Drs Kaul and MacDonald); R. Samuel McLaughlin Foundation for Molecular Medicine, University of Toronto (Dr Kaul); Department of Medicine, University Health Network, Toronto (Dr Kaul); Department of Microbiology, Mount Sinai Hospital, Toronto (Dr MacDonald); Department of Medical Statistics, Leiden University Medical Centre, Leiden, the Netherlands (Dr Nagelkerke); Departments of Medical Microbiology (Drs Nagelkerke, Maclean, and Ronald) and Community Health Sciences and Medicine (Dr Moses), University of Manitoba, Winnipeg; International Centre for Reproductive Health, Department of Obstetrics and Gynaecology, University of Ghent, Ghent, Belgium (Drs Fonck and Temmerman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Antibiotic Chemoprophylaxis and HIV Infection in Kenyan Sex Workers
Richard Steen, Gina Dallabetta, and Graham Neilsen
JAMA. 2004;292(8):921.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficacy of a Brief Behavioral Intervention to Promote Condom Use Among Female Sex Workers in Tijuana and Ciudad Juarez, Mexico
Patterson et al.
AJPH 2008;98:2051-2057.
ABSTRACT | FULL TEXT  

Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies
Nagot et al.
Sex. Transm. Infect. 2007;83:365-368.
ABSTRACT | FULL TEXT  

Possible reasons for an increase in the proportion of genital ulcers due to herpes simplex virus from a cohort of female bar workers in Tanzania
Riedner et al.
Sex. Transm. Infect. 2007;83:91-96.
ABSTRACT | FULL TEXT  

STI declines among sex workers and clients following outreach, one time presumptive treatment, and regular screening of sex workers in the Philippines.
Wi et al.
Sex. Transm. Infect. 2006;82:386-391.
ABSTRACT | FULL TEXT  

Estimation of the sexual transmission of HIV in Kenya and Uganda on the trans-Africa highway: the continuing role for prevention in high risk groups
Morris and Ferguson
Sex. Transm. Infect. 2006;82:368-371.
ABSTRACT | FULL TEXT  

Methodological lessons from a cohort study of high risk women in Tanzania
Hoffmann et al.
Sex. Transm. Infect. 2004;80:ii69-ii73.
ABSTRACT | FULL TEXT  

Other articles noted
Evid. Based Med. 2004;9:e5-e5.
FULL TEXT  

Antibiotic Chemoprophylaxis and HIV Infection in Kenyan Sex Workers
Steen et al.
JAMA 2004;292:921-921.
FULL TEXT  

Evidence-Based Global Health
Buekens et al.
JAMA 2004;291:2639-2641.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.